{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,11]],"date-time":"2026-05-11T01:58:38Z","timestamp":1778464718911,"version":"3.51.4"},"reference-count":50,"publisher":"Elsevier BV","issue":"11","license":[{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"vor","delay-in-days":365,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Transplantation and Cellular Therapy"],"published-print":{"date-parts":[[2022,11]]},"DOI":"10.1016\/j.jtct.2022.07.025","type":"journal-article","created":{"date-parts":[[2022,7,30]],"date-time":"2022-07-30T09:02:51Z","timestamp":1659171771000},"page":"763.e1-763.e7","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"title":["Predictive Factors and Outcomes after Allogeneic Stem Cell Transplantation for Adults with Acute Lymphoblastic Leukemia in Brazil"],"prefix":"10.1016","volume":"28","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5958-3181","authenticated-orcid":false,"given":"Wellington F.","family":"Silva","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dalila N.","family":"Cysne","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4441-9212","authenticated-orcid":false,"given":"Mariana N.","family":"Kerbauy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Iago","family":"Colturato","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ana Carolina A.","family":"Maia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Luciana","family":"Tucunduva","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2816-3077","authenticated-orcid":false,"given":"George M.N.","family":"Barros","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Verg\u00edlio A.R.","family":"Colturato","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nelson","family":"Hamerschlak","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vanderson","family":"Rocha","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jtct.2022.07.025_bib0001","doi-asserted-by":"crossref","first-page":"3504","DOI":"10.1200\/JCO.2017.77.3648","article-title":"New approaches to the management of adult acute lymphoblastic leukemia","volume":"36","author":"Bassan","year":"2018","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.jtct.2022.07.025_bib0002","doi-asserted-by":"crossref","first-page":"2816","DOI":"10.1200\/JCO.2004.07.130","article-title":"Outcome of allogeneic hematopoietic stem-cell transplantation in adult patients with acute lymphoblastic leukemia: no difference in related compared with unrelated transplant in first complete remission","volume":"22","author":"Kiehl","year":"2004","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.jtct.2022.07.025_bib0003","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1182\/hematology.2021000225","article-title":"Relapsed ALL: CAR T vs transplant vs novel therapies","volume":"2021","author":"Frey","year":"2021","journal-title":"Hematology Am Soc Hematol Educ Program"},{"key":"10.1016\/j.jtct.2022.07.025_bib0004","doi-asserted-by":"crossref","first-page":"3346","DOI":"10.1002\/cncr.30737","article-title":"Comparing outcomes of matched related donor and matched unrelated donor hematopoietic cell transplants in adults with B-cell acute lymphoblastic leukemia","volume":"123","author":"Segal","year":"2017","journal-title":"Cancer"},{"key":"10.1016\/j.jtct.2022.07.025_bib0005","doi-asserted-by":"crossref","first-page":"3634","DOI":"10.1200\/JCO.2008.20.2960","article-title":"Myeloablative hematopoietic cell transplantation for acute lymphoblastic leukemia: analysis of graft sources and long-term outcome","volume":"27","author":"Tomblyn","year":"2009","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.jtct.2022.07.025_bib0006","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1186\/s12885-018-4670-5","article-title":"Influence of pre-transplant minimal residual disease on prognosis after Allo-SCT for patients with acute lymphoblastic leukemia: systematic review and meta-analysis","volume":"18","author":"Shen","year":"2018","journal-title":"BMC Cancer"},{"key":"10.1016\/j.jtct.2022.07.025_bib0007","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1186\/s13045-021-01065-7","volume":"14","author":"Nagler","year":"2021","journal-title":"J Hematol Oncol"},{"key":"10.1016\/j.jtct.2022.07.025_bib0008","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1182\/bloodadvances.2021004916","article-title":"Haploidentical vs sibling, unrelated, or cord blood hematopoietic cell transplantation for acute lymphoblastic leukemia","volume":"6","author":"Wieduwilt","year":"2022","journal-title":"Blood Adv"},{"key":"10.1016\/j.jtct.2022.07.025_bib0009","article-title":"Treating adult acute lymphoblastic leukemia in Brazil\u2014increased early mortality using a German multicenter acute lymphoblastic leukemia-based regimen","volume":"18:e255-e259","author":"da","year":"2018","journal-title":"Clin Lymphoma Myeloma Leuk"},{"key":"10.1016\/j.jtct.2022.07.025_bib0010","doi-asserted-by":"crossref","first-page":"95","DOI":"10.46765\/2675-374X.2021v2n2p95","article-title":"Overall survival in patients with acute lymphoblastic leukemia treated with CALGB 8811 protocol in low income country","volume":"2","author":"Gurgel","year":"2021","journal-title":"J Bone Marrow Transplant Cell Ther"},{"key":"10.1016\/j.jtct.2022.07.025_bib0011","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/j.clml.2014.03.004","article-title":"Feasibility and outcome of the hyper-CVAD regimen in patients with adult acute lymphoblastic leukemia","volume":"15","author":"Portugal","year":"2015","journal-title":"Clin Lymphoma Myeloma Leuk"},{"key":"10.1016\/j.jtct.2022.07.025_bib0012","doi-asserted-by":"crossref","first-page":"S252","DOI":"10.1016\/j.clml.2017.07.012","article-title":"Retrospective study of adults with acute lymphoid leukemia in Mexico City: first report of the Working Group for Acute Leukemia (GTLA)","volume":"17","author":"Crespo-Solis","year":"2017","journal-title":"Clin Lymphoma Myeloma Leuk"},{"key":"10.1016\/j.jtct.2022.07.025_bib0013","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1016\/j.blre.2018.08.002","article-title":"The emerging story of acute lymphoblastic leukemia among the Latin American population \u2013 biological and clinical implications","volume":"33","author":"Quiroz","year":"2019","journal-title":"Blood Rev"},{"key":"10.1016\/j.jtct.2022.07.025_bib0014","series-title":"WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues (Revised 4th Edition)","year":"2017"},{"key":"10.1016\/j.jtct.2022.07.025_bib0015","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1016\/j.jbi.2008.08.010","article-title":"Research electronic data capture (REDCap)\u2013a metadata-driven methodology and workflow process for providing translational research informatics support","volume":"42","author":"Harris","year":"2009","journal-title":"J Biomed Inform"},{"key":"10.1016\/j.jtct.2022.07.025_bib0016","doi-asserted-by":"crossref","first-page":"1628","DOI":"10.1016\/j.bbmt.2009.07.004","article-title":"Defining the intensity of conditioning regimens: working definitions","volume":"15","author":"Bacigalupo","year":"2009","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.jtct.2022.07.025_bib0017","series-title":"The EBMT Handbook: Hematopoietic Stem Cell Transplantation and Cellular Therapies","first-page":"307","article-title":"Graft failure","author":"Valc\u00e1rcel","year":"2019"},{"key":"10.1016\/j.jtct.2022.07.025_bib0018","first-page":"825","article-title":"1994 Consensus Conference on Acute GVHD Grading","volume":"15","author":"Przepiorka","year":"1995","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.jtct.2022.07.025_bib0019","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1053\/bbmt.2003.50026","article-title":"Chronic graft-versus-host disease","volume":"9","author":"Lee","year":"2003","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.jtct.2022.07.025_bib0020","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1097\/00007890-197410000-00001","article-title":"Clinical manifestations of graft-versus-host disease in human recipients of marrow from HL-A-matched sibling donors","volume":"18","author":"Glucksberg","year":"1974","journal-title":"Transplantation"},{"key":"10.1016\/j.jtct.2022.07.025_bib0021","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1038\/leu.2011.230","article-title":"NIH-defined graft-versus-host disease after reduced intensity or myeloablative conditioning in patients with acute myeloid leukemia","volume":"26","author":"Terwey","year":"2012","journal-title":"Leukemia"},{"key":"10.1016\/j.jtct.2022.07.025_bib0022","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1038\/sj.bmt.1705727","article-title":"Competing risk analysis using R: an easy guide for clinicians","volume":"40","author":"Scrucca","year":"2007","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.jtct.2022.07.025_bib0023","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1038\/bmt.2012.282","article-title":"Suggestions on the use of statistical methodologies in studies of the European Group for Blood and Marrow Transplantation","volume":"48(suppl 1)","author":"Iacobelli","year":"2013","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.jtct.2022.07.025_bib0024","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/S0167-7152(96)00128-9","article-title":"Unifying the derivations for the Akaike and corrected Akaike information criteria","volume":"33","author":"Cavanaugh","year":"1997","journal-title":"Stat Probab Lett"},{"key":"10.1016\/j.jtct.2022.07.025_bib0025","article-title":"Determining the optimal number and location of cutoff points with application to data of cervical cancer","volume":"12","author":"Chang","year":"2017","journal-title":"PLoS One"},{"key":"10.1016\/j.jtct.2022.07.025_bib0026","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1198\/tech.2002.s656","article-title":"Modeling survival data: extending the Cox model","volume":"44","author":"Lin","year":"2002","journal-title":"Technometrics"},{"key":"10.1016\/j.jtct.2022.07.025_bib0027","doi-asserted-by":"crossref","first-page":"1827","DOI":"10.1182\/blood-2007-10-116582","volume":"111","author":"Goldstone","year":"2008","journal-title":"Blood"},{"key":"10.1016\/j.jtct.2022.07.025_bib0028","doi-asserted-by":"crossref","first-page":"1597","DOI":"10.1016\/j.bbmt.2019.04.014","article-title":"Allogeneic stem cell transplantation for acute lymphoblastic leukemia in adolescents and young adults","volume":"25","author":"Hangai","year":"2019","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.jtct.2022.07.025_bib0029","doi-asserted-by":"crossref","DOI":"10.3389\/fped.2021.796426","article-title":"Haematopoietic stem cell transplantation in adolescents and young adults with acute lymphoblastic leukaemia: special considerations and challenges","volume":"9","author":"Calvo","year":"2022","journal-title":"Front Pediatr"},{"key":"10.1016\/j.jtct.2022.07.025_bib0030","doi-asserted-by":"crossref","first-page":"e7","DOI":"10.1016\/j.clml.2014.07.006","article-title":"Prognostic factors in adolescent and adult patients with acute lymphoblastic leukemia with two protocols of chemotherapy: a cross-sectional study","volume":"15","author":"Pinheiro","year":"2015","journal-title":"Clin Lymphoma Myeloma Leuk"},{"key":"10.1016\/j.jtct.2022.07.025_bib0031","unstructured":"Neto MPQ, da Costa L, Lisboa ESA, et al. Survival benefit of pediatric-based regimen for adults with acute lymphoblastic leukemia: a single-center retrospective cohort [e-pub ahead of print]. Hematol Transfus Cell Ther. 2021 Dec 9;S2531-1379(21)01322-5."},{"key":"10.1016\/j.jtct.2022.07.025_bib0032","doi-asserted-by":"crossref","first-page":"139","DOI":"10.3324\/haematol.2016.145631","article-title":"Improving results of allogeneic hematopoietic cell transplantation for adults with acute lymphoblastic leukemia in first complete remission: an analysis from the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation","volume":"102","author":"Giebel","year":"2017","journal-title":"Haematologica"},{"key":"10.1016\/j.jtct.2022.07.025_bib0033","doi-asserted-by":"crossref","first-page":"828","DOI":"10.1038\/s41409-020-01097-6","article-title":"Impact of donor type on long-term graft-versus-host disease-free\/relapse-free survival for adult acute lymphoblastic leukemia in first remission","volume":"56","author":"Yoon","year":"2021","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.jtct.2022.07.025_bib0034","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1182\/hematology.2021000258","article-title":"Increasing access to allogeneic hematopoietic cell transplant: an international perspective","volume":"2021","author":"Rocha","year":"2021","journal-title":"Hematology Am Soc Hematol Educ Program"},{"key":"10.1016\/j.jtct.2022.07.025_bib0035","doi-asserted-by":"crossref","first-page":"798","DOI":"10.1038\/s41409-018-0373-4","volume":"54","author":"Giebel","year":"2019","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.jtct.2022.07.025_bib0036","doi-asserted-by":"crossref","first-page":"2113","DOI":"10.1016\/j.bbmt.2019.08.014","article-title":"Hematopoietic cell transplantation in the treatment of adult acute lymphoblastic leukemia: updated 2019 evidence-based review from the American Society for Transplantation and Cellular Therapy","volume":"25","author":"DeFilipp","year":"2019","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.jtct.2022.07.025_bib0037","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2020.584950","article-title":"How ancestry influences the chances of finding unrelated donors: an investigation in admixed Brazilians","volume":"11","author":"Nunes","year":"2020","journal-title":"Front Immunol"},{"key":"10.1016\/j.jtct.2022.07.025_bib0038","doi-asserted-by":"crossref","first-page":"898","DOI":"10.1038\/bmt.2016.35","article-title":"Haematopoietic cell transplants in Latin America","volume":"51","author":"Gale","year":"2016","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.jtct.2022.07.025_bib0039","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1038\/s41409-020-01101-z","article-title":"Prognostic factors for survival after allogeneic transplantation in acute lymphoblastic leukemia","volume":"56","author":"Greil","year":"2021","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.jtct.2022.07.025_bib0040","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1038\/s41409-019-0687-x","article-title":"Haploidentical transplant in adult patients with acute lymphoblastic leukemia in Argentina: a comparison with matched related and unrelated donors","volume":"55","author":"Basquiera","year":"2020","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.jtct.2022.07.025_bib0042","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1038\/s41409-019-0702-2","article-title":"Allogeneic stem-cell transplantation with sequential conditioning in adult patients with refractory or relapsed acute lymphoblastic leukemia: a report from the EBMT Acute Leukemia Working Party","volume":"55","author":"Bazarbachi","year":"2020","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.jtct.2022.07.025_bib0043","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1038\/sj.bmt.1705388","article-title":"Does younger donor age affect the outcome of reduced-intensity allogeneic hematopoietic stem cell transplantation for hematologic malignancies beneficially?","volume":"38","author":"Mehta","year":"2006","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.jtct.2022.07.025_bib0044","doi-asserted-by":"crossref","first-page":"1360","DOI":"10.1182\/bloodadvances.2020003922","article-title":"Relationship of donor age and relationship to outcomes of haploidentical transplantation with posttransplant cyclophosphamide","volume":"5","author":"DeZern","year":"2021","journal-title":"Blood Adv"},{"key":"10.1016\/j.jtct.2022.07.025_bib0045","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.1016\/j.bbmt.2018.02.006","article-title":"Development of an unrelated donor selection score predictive of survival after HCT: donor age matters most","volume":"24","author":"Shaw","year":"2018","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.jtct.2022.07.025_bib0046","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/j.bbmt.2014.09.021","article-title":"Impact of donor age on outcome after allogeneic hematopoietic cell transplantation","volume":"21","author":"Rezvani","year":"2015","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.jtct.2022.07.025_bib0047","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1186\/s13045-020-00860-y","article-title":"Haploidentical donor is preferred over matched sibling donor for pre-transplantation MRD positive ALL: a phase 3 genetically randomized study","volume":"13","author":"Chang","year":"2020","journal-title":"J Hematol Oncol"},{"key":"10.1016\/j.jtct.2022.07.025_bib0048","doi-asserted-by":"crossref","first-page":"320","DOI":"10.3389\/fonc.2020.00320","article-title":"Different effects of pre-transplantation measurable residual disease on outcomes according to transplant modality in patients with Philadelphia chromosome positive ALL","volume":"10","author":"Li","year":"2020","journal-title":"Front Oncol"},{"key":"10.1016\/j.jtct.2022.07.025_bib0049","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1186\/s13045-021-01094-2","article-title":"Post-transplant cyclophosphamide containing regimens after matched sibling, matched unrelated and haploidentical donor transplants in patients with acute lymphoblastic leukemia in first complete remission, a comparative study of the ALWP of the EBMT","volume":"14","author":"Sanz","year":"2021","journal-title":"J Hematol Oncol"},{"key":"10.1016\/j.jtct.2022.07.025_bib0050","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1182\/blood.2021011281","article-title":"HLA-haploidentical vs matched unrelated donor transplants with posttransplant cyclophosphamide-based prophylaxis","volume":"138","author":"Gooptu","year":"2021","journal-title":"Blood"},{"key":"10.1016\/j.jtct.2022.07.025_bib0051","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1182\/blood-2010-01-266478","article-title":"Association of Human Development Index with rates and outcomes of hematopoietic stem cell transplantation for patients with acute leukemia","volume":"116","author":"Giebel","year":"2010","journal-title":"Blood"}],"container-title":["Transplantation and Cellular Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666636722015111?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666636722015111?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,13]],"date-time":"2025-11-13T03:04:38Z","timestamp":1763003078000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2666636722015111"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,11]]},"references-count":50,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2022,11]]}},"alternative-id":["S2666636722015111"],"URL":"https:\/\/doi.org\/10.1016\/j.jtct.2022.07.025","relation":{},"ISSN":["2666-6367"],"issn-type":[{"value":"2666-6367","type":"print"}],"subject":[],"published":{"date-parts":[[2022,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Predictive Factors and Outcomes after Allogeneic Stem Cell Transplantation for Adults with Acute Lymphoblastic Leukemia in Brazil","name":"articletitle","label":"Article Title"},{"value":"Transplantation and Cellular Therapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jtct.2022.07.025","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 The American Society for Transplantation and Cellular Therapy. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}